Citadel Advisors’s Repare Therapeutics RPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.3M | Hold |
|
|||||
|
2025
Q1 | $924K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $354K | Sell |
|
|||||
|
2024
Q2 | $463K | Buy |
|
|||||
|
2024
Q1 | $314K | Buy |
|
|||||
|
2023
Q4 | $340K | Sell |
|
|||||
|
2023
Q3 | $1.44M | Sell |
|
|||||
|
2023
Q2 | $2.27M | Buy |
|
|||||
|
2023
Q1 | $95K | Sell |
|
|||||
|
2022
Q4 | $2.83M | Sell |
|
|||||
|
2022
Q3 | $3.8M | Buy |
|
|||||
|
2022
Q2 | $1.97M | Buy |
|
|||||
|
2022
Q1 | $839K | Sell |
|
|||||
|
2021
Q4 | $1.36M | Sell |
|
|||||
|
2021
Q3 | $1.73M | Sell |
|
|||||
|
2021
Q2 | $6.76M | Buy |
|
|||||
|
2021
Q1 | $992K | Buy |
|
|||||
|
2020
Q4 | $396K | Buy |
|
|||||
|
2020
Q3 | $243K | Sell |
|
|||||
|
2020
Q2 | $700K | Buy |
|